Adjuvant trastuzumab for breast cancer: Editorial does not mention health economics of drug
| Autor: | McLaren Eh |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Gynecology
Drug medicine.medical_specialty Health economics business.industry General surgery media_common.quotation_subject medicine.medical_treatment education Hazard ratio General Engineering General Medicine Evidence-based medicine medicine.disease Breast cancer Antibodies monoclonal Trastuzumab General Earth and Planetary Sciences Medicine business Adjuvant health care economics and organizations General Environmental Science media_common medicine.drug |
| Zdroj: | BMJ. 331:1203.1 |
| ISSN: | 1468-5833 0959-8138 |
| DOI: | 10.1136/bmj.331.7526.1203 |
| Popis: | EDITOR—Why does the BMJ , which promotes itself as a journal dedicated to evidence based medicine, publish an editorial that talks only of the hazard ratio of a treatment without any reference to the absolute reduction in recurrence observed? … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|